1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY PRODUCT
5.1. Introduction
5.2. ECMO Machine
5.3. Software
6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY COMPONENT
6.1. Introduction
6.2. Pumps
6.3. Oxygenators
6.4. Cannul
6.5. Accessories
7. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY MODALITY OUTLOOK
7.1. Introduction
7.2. Veno-Venous
7.3. Veno-Arterials
7.4. Arterio-Venous
8. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic plc
10.2. LivaNova
10.3. Terumo Cardiovascular Systems Corporation
10.4. Nipro Medical Corporation
10.5. Microport Scientific Corporation
10.6. Getinge AB
10.7. Xenios AG
10.8. EUROSETS
10.9. ABIOMED
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES